28159 AVENUE STANFORD, VALENCIA, CA
AVITA Medical Enters $60 Million Credit Agreement with Perceptive
Material disclosure
Reports First Quarter 2026 Financial Results
Names Cary Vance as Chief Executive Officer
Financial Results, Press Release
Pre-J.P. Morgan Update Highlights 2025 Revenue Growth, New Debt Facility, and 2026 Growth Outlook
Announces Changes to its Board of Directors
Reports Third Quarter 2025 Financial Results
Q1
FY 2024
Q3
Q2
FY 2023
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Correspondence
Submission Upload